final_ipd dm version 2012

Upload: kamolpat-chaiyakittisophon

Post on 08-Oct-2015

93 views

Category:

Documents


4 download

DESCRIPTION

DM

TRANSCRIPT

  • 0

    Clinical Practice Guidelines for In-patients with Diabetes Mellitus,

    Department of Medicine Maharat Nakhon Ratchasima Hospital

    .. 2555

  • 1

    (DIABETES MELLITUS)

    (Diabetes mellitus, DM) 4 1 2 2 1 (diabetic ketoacidosis, DKA) (hypoglycemia) (hyperosmolar hyperglycemic syndrome, HHS) (diabetic ketoacidosis, DKA)

  • 2

    2553 1,880 re-admit 28 604 16.8 612 2.3 sepsis myocardial infarction

    2553 (hypoglycemia at admission) 77 (in-hospital hypoglycemia) 989 DM type 1 with DKA 15 DM type 2 with DKA 36 DM type 2 with coma (HHS) 134

    2554 3,588 764 21.3 re-admit 28 604 16.8

    2554 (hypoglycemia at admission) 77 (in-hospital hypoglycemia) 1,083 DM type 1 with DKA 22 DM type 2 with DKA 86 DM type 2 with coma (HHS) 143

  • 3

    1. (mortality rate) 2. (morbidity rate) 3. 4. (re-admission) 1. (capillary blood sugar) (non-critical care setting) 2. (Hypoglycemia)

    3. 4. (Hyperosmolar hyperglycemic syndrome, HHS) (Diabetic ketoacidosis, DKA) 5. 6.

  • 4

    ( 26 .. 2555)

    CPG for In-patients with Diabetes Mellitus ( 1)

    DKA = Diabetic Ketoacidosis HHS = Hyperosmolar Hyperglycemic Syndrome

    .. ..

    Hypoglycemia (3, 4)

    DKA (5)

    HHS (5)

    (6, 7)

    Yes

    Yes

    Yes

    (2) BS non-critical care

  • 5

    CPG for Blood Sugar Assessment and Monitoring in In-patients with Non-critical Care Setting ( 2)

    Hyperglycemia 1. Plasma Glucose at Admission

    1 in-hospital hyperglycemia 140 mg/dl

    2. capillary blood sugar (CBS) ( 3 - 7)

    3. CBS corticosteroids, enteral nutrition parenteral nutrition CBS 24-48

    4. CBS > 140 mg/dl CBS 24-48

    5. CBS >140 mg/dl HbA1c 3

    Capillary Blood Sugar (CBS) 1. CBS (accuracy)

    plasma glucose 2. CBS

    3. (NPO) continuous enteral feeding

    CBS 6 4.

    - 140 mg/dl - 180 mg/dl

    Adapted from J Clin Endocrinol Metab. 2012; 97:1638.

  • 6

    (Hypoglycemia)

    Treatment of In-patients with Hypoglycemia ( 3)

    Hospitalized patient PAPPAPpatient

    PG < 70 mg/dl with Symptoms sweating, palpitation, blurred vision, confusion, slurred speech, tired weakness, drowsiness, headache, hunger, irritability or coma

    Start Treatment CBS < 70 - + 1 15-30 g

    CHO - + 50% glucose 20 . IV

    5-10% Dextrose 100 ml/hr - 50% glucose 25 . IV

    5-10% dextrose 100 ml/hr Monitor CBS 1/2 - 1 . CBS > 100 mg/dl 2

    DM hypoglycemia plasma glucose < 50 mg/dl

    Clot blood 5 . insulin,

    cortisol, GH hypoglycemia

    Monitor CBS 2 6 keep CBS 100 180 mg/dl Hypoglycemia

    - hypoglycemia - * - ** -

    Follow up Education 1

    * ** hypoglycemia

    hypoglycemia plasma glucose

    PG = Plasma Glucose CBS = Capillary blood sugar

    Adapted from J Clin Endocrinol Metab. 2012; 97:1638.

  • 7

    1

  • 8

    - o o ward

    - / o (repeated hypoglycemia)

    o 5

    - o

    (hypoglycemia at admission)

    - o

    (drug induced hypoglycemia)

  • 9

    Nutritional Assessment for In-patients ( 4)

    4

    1. Body Mass Index (BMI) * - BMI 18.5 22.5 Normal = 0

    - BMI 17.5 18.4 Thin = 1 - BMI < 17.4 = 2

    2. Weight loss - < 5 % = 0 - 5-10 % = 1 - > 10% = 2

    3. Apetite - < 50% = 1 - NPO > 5 = 2

    4. Serum albumin - serum albumin 2.6 3.0 g/dL = 1 - serum albumin < 2.5 g/dL = 2

    *BMI = body weight (kg)/ height 2 (m2)

    - 2

    - < 2 1

  • 10

    2

    * ** drip < 50% TPN

    - > 65 , BMI < 17.5 kg/m2, alcoholism Serum electrolyte, BUN, Magnesium phosphate 24-48

  • 11

    Hyperosmolar Hyperglycemic Syndrome (HHS) Diabetic Ketoacidosis (DKA)

    Treatment of In-patients with DKA and HHS ( 5)

    DKA HHS

    Start IV Fluid - NSS 1000 cc/hr 1 - NSS NSS/2 250- 500 cc/hr

    IV fluid degree of dehydration serum Na

    Start IV Insulin therapy - RI 0.1 U/kg IV bolus RI 0.1 U/kg/hr

    rate RI IV fluid PG 50-75 mg/dl/hr

    - Add 5-10% Dextrose PG level 200-300 mg/dl rate RI IV fluid maintain PG 150-200 mg/dl

    Initiate Potassium Replacement - Normokalemia (3.3-5.2) : Add KCl 20-30

    mEq in IV 1000 cc. - Hypokalemia ( 3.3

    - K > 5.0 mEq/L or no urine output : Not need K replacement

    - DKA / HHS

    - consult Endocrine consult

    DKA : most common in DM type 1 - Serum glucose > 250 mg/dl - Positive serum ketone* - Wide gap metabolic acidosis

    ( arterial pH < 7.3, serum HCO3 < 15 meq/L and anion gap** > 12 )

    HHS : most common in DM type 2 - Serum glucose > 600 mg/dl - Effective serum osmolarity #>320

    mOsm/L

    Monitoring : Check PG CBS 1 . PG CBS ~ 200-300 mg/dl then check CBS 2-4 .

    : Check Electrolyte 2-4 . hypokalemia

    Additional Electrolyte Replacement - Bicarbonate : in severe acidosis

    pH < 6.9 : NaHCO3 100 cc IV in 2 hr

    - not need NaHCO3 if pH 6.9

    * Positive serum ketone = Serum beta hydroxybutyrate > 3 mg/dL, Moderate positive the nitroprusside test (dilute sample 1:1) ** Anion gap = serum Na (Cl + HCO3) # Effective serum osmolarity = 2 [serum Na] + glucose/18 PG = Plasma Glucose CBS = Capillary blood sugar

    Adapted from ADA 2009

  • 12

    Treatment of DM In-patients with Illness ( 6) (Not Diabetic Emergency)

    PG = Plasma Glucose CBS = Capillary blood sugar

    ..

    NPO ?

    5% D/N/2 RI ( 7) Add RI IV fluid RI IV drip RI SC q 6 h Supplemental insulin scale

    - CBS - FPG 80-180

    mg/dl

    - insulin

    CBS q 1 hr until stable (keep PG 80-180 mg/dl)

    BS < 100 mg/dl BS 100-180(200) mg/dl BS > 180(200) mg/dl

    - Insulin - BS < 70 mg/dl insulin

    + 50% glucose IV - CBS q -1 hr until CBS > 100

    CBS q 6 hr

    1. RI IV fluid drip

    2. RI intravenous drip 3. Supplemental

    insulin scale

    CBS q 2-6 hr

    No

    Yes

    Adapted from J Clin Endocrinol Metab. 2012; 97:1638.

  • 13

    Insulin ( 7)

    A. (NPO) insulin

    1. RI IV fluid with Dextrose

    - CBS 200 mg/dl add RI 5% D/N/2 1,000 cc 201 250 mg/dl add RI 5 unit 5% D/N/2 1,000 cc 251 300 mg/dl add RI 10 unit 5% D/N/2 1,000 cc > 300 mg/dl RI 5 unit intravenous

    - CBS IV fluid 1 . CBS 201 250 mg/dl add RI 2 unit 5% D/N/2 1,000 cc 251 300 mg/dl add RI 4 unit 5% D/N/2 1,000 cc > 300 mg/dl RI intravenous

    - CBS 100 180(200) mg/dl CBS q 6 hr

    2. RI intravenous drip IV fluid with Dextrose

    - RI intravenous drip 0.5 1 unit/hr RI : NSS 1:1 1: 25 RI 20 unit NSS/2 500 cc (25 cc = RI 1 unit 1 cc = RI 0.04 unit)

    - drip RI intravenously infusion pump

    - CBS RI intravenous drip rate insulin CBS 120-200 mg/dl

    3. RI subcutaneuos injection Supplemental insulin scale CBS

    Adapted from J Clin Endocrinol Metab. 2012; 97:1638.

  • 14

    1 Supplemental insulin scale (RI rapid acting insulin)

    Blood Glucose (mg/dl) Insulin-sensitive Usual Insulin-resistant

    >141- 180 2 4 6

    181- 220 4 6 8

    221- 260 6 8 10

    261- 300 8 10 12

    301 350 10 12 14

    351 400 12 14 16

    >400 14 16 18

    - sliding scale Schedule insulin regimens (Basal Bolus Insulin Injection)

    - RI (2-4 unit 10-20 % ) ,

    - RI 2-4 unit 80 unit .

    - Schedule insulin regimens (Basal Bolus subcutaneous insulin injection) overlapping period 2 Subcutaneuos insulin injection RI intravenous drip 1-2

    Adapted from J Clin Endocrinol Metab. 2012; 97:1638.

  • 15

    B. insulin

    1. Scheduled insulin regimen (Basal Bolus subcutaneous insulin injection) - Total insulin dosage

    - RI 1 ( intravenous insulin drip rate ) - 0.2-0.3 U/kg/day 70 / GFR < 60 ml/min - 0.4 U/kg/day

    140-200 mg/dl - 0.5 U/kg/day 201-400 mg/dl

    - 1/2 total insulin Basal insulin NPH () glargine/determir insulin 1

    - 1/2 total insulin Prandial insulin RI ( rapid acting insulin)

    - insulin CBS 80-180 (200) mg/dl CBS - renal/liver insufficiency Basal insulin NPH ac prandial insulin

    2. Supplemental subcutaneous insulin injection - supplemental insulin injection scheduled insulin regimen supplemental insulin scale ** > 300 mg/dl ()

    Adapted from J Clin Endocrinol Metab. 2012; 97:1638.

  • 16

    Care Map

    CARE MAP OF HYPOGLYCEMIA

    Day Assessment Specimen/test Medication Activity / diet Planning discharge

    1. /

    Hemodynamic assessment

    VS. q 1-2 hrs / 4-6 hrs

    **

    CBS q - 1 hr stable

    hypoglycemia CBC, UA, Urine C/S Hemoculture, BUN, Cr. Electrolyte etc.

    50% glucose IV*

    IV fluid*

    precipitating causes

    NPO/soft diet hypoglycemia

    Education ../ hypoglycemia

    2.

    VS. q 4-6 hrs

    CBS q 4-6 hr Follow up Labs

    IV fluid* NPO/soft diet ***

    Education .. / hypoglycemia

    follow up 3.

    VS. q 4-6 hrs

    CBS tid ac & hs Antidiabetic drugs

    Soft / regular diabetic diet

    Education .. / hypoglycemia

    follow up

    * glucose IV fluid 3 ** 4 *** 1

  • 17

    CARE MAP FOR DKA / HHS

    Day Assessment Specimen/test Medication Activity / diet

    Planning discharge

    1. /

    Hemodynamic assessment

    VS. q 1-2 hrs / 4-6 hrs

    CBS q 1 hr BUN, Cr Electrolyte q 2-4 hr Serum ketone ABG EKG, CXR

    CBC, UA, Urine C/S Hemoculture, etc.

    RI* IV fluid* K, HCO3

    * RX precipitating

    causes

    NPO Consult Endocrine

    Education

    2.

    VS. q 4-6 hrs

    CBS q 4-6 hr BUN, Cr, electrolyte Follow up Labs

    RI* IV fluid* RX precipitating

    causes

    NPO/soft diet

    Education .. /

    follow up 3.

    VS. q 4-6 hrs

    CBS tid ac & hs NPH/RI Pre-mixed insulin

    RX precipitating causes

    Soft / regular diabetic diet

    Education .. /

    follow up

    * RI & IV fluid 5

  • 18

    CARE MAP FOR DM IN-PATIENTS WITH ILLNESS

    Day Assessment Specimen/test Medication Activity / diet

    Planning discharge

    1. /

    Hemodynamic assessment

    VS. q 1-2 hrs / 4-6 hrs

    CBS q 1 hr BUN, Cr Electrolyte Investigate cause of

    illness CBC, UA, Urine C/S Hemoculture, etc.

    Insulin (NPH/RI)*

    IV fluid* RX / support Rx

    of causes of illness

    NPO/diabetic diet

    Education

    2.

    VS. q 4-6 hrs

    CBS q 4-6 hr Follow up Labs

    Insulin (NPH/RI)*

    IV fluid* RX / support Rx

    of causes of illness

    NPO/diabetic diet

    Education .. / ..

    follow up

    3.

    VS. q 4-6 hrs

    CBS tid ac & hs Antidiabetic drugs*

    NPH/RI* IV fluid* Rx / support Rx

    of causes of illness

    diabetic diet

    Education .. / ..

    follow up

    * Insulin & IV fluid 6 7

  • 19

    1. . 2. . 3. . 4. . 5. . 6. .. 7. .. 8. 8 9.

    10. 11. 12. 13. 14. 15. 16.

  • 20

    1. American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2012; 35 supp 1: s64-71.

    2. . . 2546 15 28.

    3. 2553-2554.

    4. . . 2546 359 385.

    5. Umpierrez GE, Hellman R, Korytkowski MT, Kosiborod M, Maynard GA, Montori VM, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012; 97: 16-38.

    6. Kitabchi AE, Umpierrez GE, Miles JM, Fisher JN. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009; 32: 1335-43.

    7. Gordon C. Weir. Insulin Therapy and Its Complications. In : Kenneth L. Becker. Principles and Practice of Endocrinology and Metabolism 3rd Edition. LWW. Philadelphia 2001: p 1348-59.

    8. . . 2546 133 152.

  • 21

    - insulin

    - hypoglycemia

    - DKA chart

    - Diabetic chart

    -

  • 22

    Insulin

  • 23

    HYPOGLYCEMIA

    - ..................................................................................HN......................... hypoglycemia .................................................................................... Diagnosis..

    1) Capillary blood sugarmg/dl and/or Plasma glucose..mg/dl ()

    2) [ ] Hypoglycemia at Admission [ ] In-hospital Hypoglycemia, one episode [ ] In-hospital Hypoglycemia, recurrent (> 2 episodes)

    3) Cause of hypoglycemia [ ] Oral hypoglycemic drug induced hypoglycemia [ ] Insulin induced hypoglycemia [ ] Poor intake (< 50%) or NPO [ ] Sepsis [ ] Others (specify)....

    4) [ ] Consult Endocrine [ ] Consult Nutrition [ ] Consult ( Doctor Order) [ ] Consult ( Doctor Order)

    [ ] [ ] ...................................................................................................................................

  • 24

  • 25

  • 26

  • 27

    Nutrition Alert Form:

    1. // 2 (Arm span) : :

    ( )

    2. [ (BMI) = (.) ( (.) (.))] : 3 : Albumin Albumin Total Lymphocyte Count (TLC) [TLC = (Total WBC Lymphocyte) 100]

    3. :

    4. 4 :

    5. 2 : (Clear liquid diet: ) (Full liquid diet: )

    (Soft diet: )

    (Regular diet: ) - :

    6. > 2 ( 1 ):

    7. :

    8. / ( 1 ) CKD-ESRD :

    rejection Solid cancer : Lymphoma (Leukemia)

    (Tumor)